The methodology included: Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, including major players such as Altria Group Inc., British American Tobacco PLC, Philip Morris International (Swedish Match), Imperial Brands PLC, Japan Tobacco Inc., DS Group Ltd., Swisher International, Hay Island Holding Corporation, and Kretek International Product mapping across chewing tobacco, moist snuff, dry snuff, snus, dissolvable tobacco, and emerging nicotine pouch categories by form (loose leaf, plug, twist, pouch/portions) Analysis of reported and modeled annual revenues specific to smokeless tobacco portfolios using FTC filings, company annual reports, and trade association disclosures Coverage of manufacturers representing 70-75% of global market share in 2024 Extrapolation using bottom-up (unit volume by country average selling price by product type) and top-down (manufacturer revenue validation against retail tracking data) approaches to derive segment-specific valuations, cross-referenced with customs/trade data (UN Comtrade, national import/export statistics) for volumetric validation Download Free Sample Kindly complete the form below to receive a free sample of this Report This is really good guys
Reference Hemani, Tilling and Davey Smith26 For smoking initiation, lifetime smoking and bipolar disorder, we reported the number of variants that were used in the bidirectional analyses after removing insertions or deletions and harmonisation of the data (Table 1)
Cigarette smoking among US youth has become increasingly denormalised since 2015, while e-cigarette norms have shown greater variability
This is where using a non-penetrating syringe works better than an eye-dropper, but an eye-dropper can still be used
